Cargando…
Prevention of migraine by supraorbital transcutaneous neurostimulation using the Cefaly® device (PREMICE): a multi-centre, randomized, sham-controlled trial
Autores principales: | Schoenen, J, Vandersmissen, B, Jeangette, S, Herroelen, L, Vandenheede, M, Gerard, P, Magis, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620126/ http://dx.doi.org/10.1186/1129-2377-14-S1-P184 |
Ejemplares similares
-
Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly(®) Device for Migraine Prevention: A Review of the Available Data
por: Riederer, Franz, et al.
Publicado: (2015) -
Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population
por: Magis, Delphine, et al.
Publicado: (2013) -
Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects
por: Piquet, Maxime, et al.
Publicado: (2011) -
A survey on migraine attack treatment with the CEFALY(®) device in regular users
por: Penning, Sophie, et al.
Publicado: (2017) -
Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience
por: Russo, Antonio, et al.
Publicado: (2015)